$116.49
00.00%
Pre-Market: 4:00 PM EDT
15 minutes delayed
Comments
Loading...
Latest news for Neurocrine Biosciences (NASDAQ:NBIX) Stock
Neurocrine Biosciences Stock (NASDAQ: NBIX)
Categories: All
Monday, September 16, 2024
Friday, September 13, 2024
Thursday, September 12, 2024
Monday, September 09, 2024
Sunday, September 08, 2024
Monday, September 02, 2024
Thursday, August 29, 2024
- Neurocrine Biosciences shares are trading hig...
- Neurocrine Biosciences' Lower Dose Data Puts Its Schizophrenia Candidate In The Game, Analyst Upgrades Stock
- Cantor Fitzgerald Maintains Overweight on Neu...
- RBC Capital Maintains Sector Perform on Neuro...
- NVIDIA To Rally Over 31%? Here Are 10 Top Analyst Forecasts For Thursday
- HC Wainwright & Co. Reiterates Buy on Neurocr...
- Needham Reiterates Hold on Neurocrine Bioscie...
- Piper Sandler Upgrades Neurocrine Biosciences...
- BMO Capital Maintains Market Perform on Neuro...
Wednesday, August 28, 2024
- Nasdaq Down Over 1%; Foot Locker Shares Tumble After Q2 Results
- As Regulators Gear Up To Decide On Bristol Myers' Schizophrenia Treatment, Neurocrine Biosciences' Data Disappoints Investors
- US Stocks Mixed; JM Smucker Slashes Annual Guidance
- Neurocrine Biosciences shares are trading low...
- Neurocrine Biosciences Announced Positive Top...